These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Designer estrogens: breast cancer benefit, remaining questions. Health News; 1999 Jul; 5(9):6. PubMed ID: 10480007 [No Abstract] [Full Text] [Related]
8. Tamoxifen for flutamide/finasteride-induced gynecomastia. Staiman VR; Lowe FC Urology; 1997 Dec; 50(6):929-33. PubMed ID: 9426725 [TBL] [Abstract][Full Text] [Related]
9. Preventing breast cancer with tamoxifen. Health News; 1998 May; 4(6):1, 5. PubMed ID: 9602560 [No Abstract] [Full Text] [Related]
10. Tamoxifen for breast cancer prevention. Jpn J Clin Oncol; 1998 Dec; 28(12):775-6. PubMed ID: 9879301 [No Abstract] [Full Text] [Related]
11. Chemoprevention of breast cancer for women at high risk. Chan K; Morris GJ Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen for breast cancer prevention. Force RW J Fam Pract; 1998 Nov; 47(5):336-7. PubMed ID: 9834765 [No Abstract] [Full Text] [Related]
13. [Agonists-antagonists of estrogens, their potential use in prophylaxis and treatment of osteoporosis]. Hoszowski K Pol Tyg Lek; 1995 Nov; 50(44-47):41-2. PubMed ID: 8643425 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tamoxifen resistance. Ring A; Dowsett M Endocr Relat Cancer; 2004 Dec; 11(4):643-58. PubMed ID: 15613444 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen for the prevention of breast cancer. Greenspan EM Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089 [No Abstract] [Full Text] [Related]
16. Chemoprevention of breast cancer with tamoxifen. Cuzick J IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120 [No Abstract] [Full Text] [Related]
17. Tamoxifen for prevention of breast cancer. Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486 [No Abstract] [Full Text] [Related]
18. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Van Poppel H Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341 [No Abstract] [Full Text] [Related]
19. Tamoxifen and breast cancer prevention: are we aware of the risks? Mandeville R; Houde M Cancer Prev Control; 1997; 1(1):66-72. PubMed ID: 9765729 [No Abstract] [Full Text] [Related]
20. Women at high risk for breast cancer. Gross RE Am J Nurs; 1998 Apr; 98(4):55-8. PubMed ID: 9556686 [No Abstract] [Full Text] [Related] [Next] [New Search]